Table 1.
Developmental efficiencies of rat ESCs at different passages for tetraploid complementation
Background | Rat ESC lines | Sex | Passage | No. injected | No. recipient | No. development in vivo (%) | |
Full-term | Live adult | ||||||
DA | Outgrowth | Male/female | — | 72 | 5 | 4F/3M (9.7) | 1F/2M (4.2) |
DAESC-4 | Male | P2 | 44 | 1 | 1 (2.3) | 1 (2.3) | |
P3 | 75 | 3 | 4 (5.3) | 1 (1.3) | |||
P4 | 152 | 5 | 2 (1.3) | 1 (0.7) | |||
P6 | 47 | 1 | 0 | 0 | |||
P7 | 37 | 1 | 1 (2.7) | 0 | |||
P10 | 121 | 3 | 0 | 0 | |||
P13 | 40 | 1 | 0 | 0 | |||
P17 | 40 | 1 | 0 | 0 | |||
DAESC-5 | Male | P3 | 110 | 4 | 3 (2.7) | 1 (0.9) | |
P4 | 58 | 2 | 0 | 0 | |||
P6 | 120 | 5 | 3 (2.5) | 1 (0.8) | |||
P7 | 40 | 1 | 0 | 0 | |||
P11 | 65 | 2 | 0 | 0 | |||
P15 | 105 | 4 | 0 | 0 | |||
P20 | 85 | 2 | 0 | 0 | |||
DAESC-6 | Male | P4 | 130 | 4 | 4 (3.1) | 1 (0.8) | |
P11–P13 | 231 | 4 | 0 | 0 | |||
DAESC-7 | Female | P2 | 45 | 2 | 0 | 0 | |
P3 | 62 | 4 | 0 | 0 | |||
P10 | 123 | 6 | 0 | 0 | |||
DAESC-8 | Female | P10–P12 | 87 | 5 | 0 | 0 | |
BN × SD | Outgrowth | Male/female | — | 30 | 1 | 1F/2M (10.0) | 2M (6.7) |
BSESC-2 | Male | P1 | 105 | 3 | 1 (0.9) | 0 | |
P2 | 109 | 3 | 0 | 0 | |||
P3 | 103 | 3 | 1 (1.0) | 0 | |||
P5 | 92 | 2 | 0 | 0 | |||
P6–P10 | 379 | 12 | 0 | 0 | |||
BSESC-3 | Female | P2–P12 | 292 | 14 | 0 | 0 |
BN × SD, Brown Norway strain mated with Sprague–Dawley strain; DA, Dark Agouti strain; F, female; M, male.